Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

The importance of residual renal function in peritoneal dialysis.

Sikorska D, Pawlaczyk K, Olewicz-Gawlik A, Czepulis N, Posnik B, Baum E, Wanic-Kossowska M, Lindholm B, Oko A.

Int Urol Nephrol. 2016 Dec;48(12):2101-2108. Epub 2016 Oct 12.

PMID:
27734218
2.

iTRAQ-based proteomic analysis of plasma reveals abnormalities in lipid metabolism proteins in chronic kidney disease-related atherosclerosis.

Luczak M, Formanowicz D, Marczak Ł, Suszyńska-Zajczyk J, Pawliczak E, Wanic-Kossowska M, Stobiecki M.

Sci Rep. 2016 Sep 7;6:32511. doi: 10.1038/srep32511.

3.

Label-Free Quantitative Proteomics Reveals Differences in Molecular Mechanism of Atherosclerosis Related and Non-Related to Chronic Kidney Disease.

Luczak M, Suszynska-Zajczyk J, Marczak L, Formanowicz D, Pawliczak E, Wanic-Kossowska M, Stobiecki M.

Int J Mol Sci. 2016 May 2;17(5). pii: E631. doi: 10.3390/ijms17050631.

4.

Usefulness of serum interleukin-18 in predicting cardiovascular mortality in patients with chronic kidney disease--systems and clinical approach.

Formanowicz D, Wanic-Kossowska M, Pawliczak E, Radom M, Formanowicz P.

Sci Rep. 2015 Dec 16;5:18332. doi: 10.1038/srep18332.

5.

Deeper insight into chronic kidney disease-related atherosclerosis: comparative proteomic studies of blood plasma using 2DE and mass spectrometry.

Luczak M, Formanowicz D, Marczak Ł, Pawliczak E, Wanic-Kossowska M, Figlerowicz M, Stobiecki M.

J Transl Med. 2015 Jan 27;13:20. doi: 10.1186/s12967-014-0378-8.

6.

The polymorphism of the ACE gene affects left ventricular hypertrophy and causes disturbances in left ventricular systolic/diastolic function in patients with autosomal dominant polycystic kidney disease.

Wanic-Kossowska M, Posnik B, Kobelski M, Pawliczak E, Pawlaczyk K, Hoppe K, Schwermer K, Sikorska D.

ScientificWorldJournal. 2014 Jan 2;2014:707658. doi: 10.1155/2014/707658. eCollection 2014.

7.

Differences in the psychological and hormonal presentation of lean and obese patients with polycystic ovary syndrome.

Komarowska H, Stangierski A, Warmuz-Stangierska I, Lodyga M, Ochmanska K, Wasko R, Wanic-Kossowska M, Ruchala M.

Neuro Endocrinol Lett. 2013;34(7):669-74.

PMID:
24464003
8.

Pregnancy in diabetic woman with coexisting hypothyroidism, coronary artery disease and with early onset nephrotic syndrome--a case report.

Wender-Ozegowska E, Zawiejska A, Wanic-Kossowska M, Ozegowski S, Brazert J, Czekalski S.

Ginekol Pol. 2012 Apr;83(4):305-8.

PMID:
22712265
9.

Vitamin K status in peritoneally dialyzed patients with chronic kidney disease.

Stankowiak-Kulpa H, Krzyżanowska P, Kozioł L, Grzymisławski M, Wanic-Kossowska M, Moczko J, Walkowiak J.

Acta Biochim Pol. 2011;58(4):617-20. Epub 2011 Dec 20.

10.

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators..

Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12.

11.

Chronic kidney disease-related atherosclerosis - proteomic studies of blood plasma.

Luczak M, Formanowicz D, Pawliczak E, Wanic-Kossowska M, Wykretowicz A, Figlerowicz M.

Proteome Sci. 2011 May 13;9:25. doi: 10.1186/1477-5956-9-25.

12.
13.

Human peritoneal fibroblasts are a potent source of neutrophil-targeting cytokines: a key role of IL-1beta stimulation.

Witowski J, Tayama H, Ksiazek K, Wanic-Kossowska M, Bender TO, Jörres A.

Lab Invest. 2009 Apr;89(4):414-24. doi: 10.1038/labinvest.2009.1. Epub 2009 Feb 2.

14.

[Renal insufficiency in diabetic pregnancy with nephropathy].

Wender-Owegowska E, Iciek R, Wanic-Kossowska M, Brazert J.

Ginekol Pol. 2007 May;78(5):411-3. Polish. No abstract available.

PMID:
17867336
15.

[Hypotonia in renal failure patients undergoing dialysis therapy].

Wanic-Kossowska M, Czekalski S.

Pol Arch Med Wewn. 2007 Apr;117(4):58-63. Review. Polish.

16.

[Combined therapy with L-carnitine and erythropoietin of anemia in chronic kidney failure patients undergoing hemodialysis].

Wanic-Kossowska M, Kazmierski M, Pawliczak E, Kobelski M.

Pol Arch Med Wewn. 2007 Jan-Feb;117(1-2):14-9. Polish.

17.

Peritoneal effects of intravenous iron sucrose administration in rats.

Breborowicz A, Polubinska A, Breborowicz M, Simon M, Wanic-Kossowska M, Oreopoulos DG.

Transl Res. 2007 Jun;149(6):304-9. Epub 2007 May 23.

PMID:
17543848
18.

Anemia treatment with darbepoetin alpha in pregnant female with chronic renal failure: report of two cases.

Sobiło-Jarek L, Popowska-Drojecka J, Muszytowski M, Wanic-Kossowska M, Kobelski M, Czekalski S.

Adv Med Sci. 2006;51:309-11.

PMID:
17357331
19.

[Effectiveness of darbepoietin alfa in anemic patients with chronic kidney disease (CKD) in predialysis period].

Wanic-Kossowska M, Tykarski A, Kobelski M, Czekalski S.

Pol Arch Med Wewn. 2006 Jul;116(1):663-70. Polish.

PMID:
17340973
20.

Hypotonia during amikacin administration in a patient treated with continuous ambulatory peritoneal dialysis.

Wanic-Kossowska M, Grzegorzewska AE, Tykarski A.

Adv Perit Dial. 2006;22:69-72.

PMID:
16983943

Supplemental Content

Loading ...
Support Center